The Methylation Cycle, MTHFR, and B Vitamins: What Research Shows

By Dr. Joey Grice

Summary: Your body uses folate, vitamin B12, and riboflavin in a daily process called methylation. A common MTHFR gene variant can reduce the activity of a key enzyme in that pathway. Here's what peer-reviewed studies show—and what they don't.

A Daily Process Your Cells Depend On

Methylation is a chemical step in which your cells attach a small "tag," called a methyl group, to DNA, proteins, and other molecules. One important job is recycling homocysteine back into methionine. The enzyme MTHFR helps make 5-methyltetrahydrofolate, the form of folate that donates that carbon tag.

In 1995, Frosst and colleagues reported a common MTHFR gene change, C677T, linked with a less stable, less active enzyme. In lymphocyte extracts, people with two copies of the variant (the TT genotype) had a mean enzyme activity of about 30% of the mean in people without it—a reduction of about 70%. People with one copy (CT) had about 65% of that activity. The TT group also had significantly higher blood homocysteine. Limitation: these figures describe enzyme activity in blood-cell extracts. They are not a finding that "methylation as a whole slows by 70%" in every person with the variant, or that the variant alone causes disease.

Folate, Vitamin B12, and the Form of Folate You Take

A 2005 meta-analysis of 25 randomized trials (2,596 people) from the Homocysteine Lowering Trialists' Collaboration found that folic acid lowered blood homocysteine, especially when starting levels were higher, with an additional 7% reduction from vitamin B12. Vitamin B6 did not add a significant effect. Limitation: the outcome was a blood marker, not whether these nutrients prevent heart disease or other conditions.

Folic acid is the synthetic form used in many supplements and fortified foods. 5-methyltetrahydrofolate, often called methylfolate, is the form the MTHFR enzyme helps produce. In a 2009 randomized crossover study of 24 women, Prinz-Langenohl and colleagues found that a single dose of methylfolate raised plasma folate more effectively than folic acid in both the TT and CC genotypes. Limitation: this was a short, single-dose study, not a long-term health trial. It is not a reason to change a pregnancy folate plan without talking with your own provider.

Riboflavin and the MTHFR 677TT Genotype

MTHFR also depends on riboflavin (vitamin B2). In a 12-week randomized trial in Circulation, McNulty and colleagues found that riboflavin lowered homocysteine only in people with the TT genotype, by about 22% overall. People with the CC or CT genotypes showed no homocysteine change. Limitation: this study in healthy adults measured homocysteine, not clinical events.

Cellular Energy Also Changes With Age

Mitochondria help make ATP, the energy currency cells use. In a study of 146 healthy adults aged 18 to 89, Short and colleagues found that mitochondrial DNA abundance in skeletal muscle, and the muscle's capacity to produce ATP, declined with advancing age. Limitation: this was a study of aging in healthy adults' muscle. It is not a national survey of "mitochondrial deficiency," and it does not test supplements.

Testing Is a Conversation, Not a Shortcut

MTHFR variants are common, and routine testing is debated. In a 2013 practice guideline, the American College of Medical Genetics and Genomics concluded that MTHFR polymorphism testing has little clinical utility in a routine evaluation for blood-clotting risk and should not be ordered for that purpose. A gene result is only one piece of a larger picture that includes diet, other nutrients, and your overall history. Supplements do not change the genes you were born with. They may support how a pathway works.

Talk With Us About a Genetic Wellness Plan

If you want a research-informed look at methylation and nutrition, Genetic Wellness Group can review your history and discuss a personalized wellness plan. We see people at our Mars, PA, and Mt. Washington offices. Visit geneticwg.com/contact to connect.

This article is for educational purposes only and is not a substitute for personalized advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk with your healthcare provider before starting or changing any supplement, especially if you are pregnant, nursing, taking medications, or managing a condition.

References

Peer-reviewed

  1. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111-113. https://pubmed.ncbi.nlm.nih.gov/7647779/

  2. Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr. 2005;82(4):806-812. https://pubmed.ncbi.nlm.nih.gov/16210710/

  3. Prinz-Langenohl R, Brämswig S, Tobolski O, et al. [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C-->T polymorphism of methylenetetrahydrofolate reductase. Br J Pharmacol. 2009;158(8):2014-2021. https://pubmed.ncbi.nlm.nih.gov/19917061/

  4. McNulty H, Dowey le RC, Strain JJ, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation. 2006;113(1):74-80. https://pubmed.ncbi.nlm.nih.gov/16380544/

  5. Short KR, Bigelow ML, Kahl J, et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A. 2005;102(15):5618-5623. https://pubmed.ncbi.nlm.nih.gov/15800038/

  6. Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genet Med. 2013;15(2):153-156. https://pubmed.ncbi.nlm.nih.gov/23288205/